ATP Life Science Ventures L.P. 13D/13G Filings for Stoke Therapeutics, Inc. (STOK)

ATP Life Science Ventures L.P. 13D and 13G filings for Stoke Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-06-28
8:54 pm
Sale		 2021-06-21 13D Stoke Therapeutics, Inc.
STOK		 ATP Life Science Ventures L.P. 1,912,256
5.200%		 -15,293,789decrease
(-88.89%)		 Filing
2020-11-27
4:58 pm
Purchase		 2020-11-20 13D Stoke Therapeutics, Inc.
STOK		 ATP Life Science Ventures L.P. 17,206,045
47.500%		 419,332increase
(+2.50%)		 Filing